Respiratory mucosal immunity against SARS-CoV-2 after mRNA vaccination
Article
[키워드] Antibody Response
B.1.617.2
BAL
Blood
booster vaccination
Breakthrough infection
Bronchoalveolar lavage fluid
cellular immunity
circulating
Combination
convalescent
COVID-19
COVID-19 vaccine
D614G
Delta
demonstrated
effective
elicit
hospitalized patients
humoral
immune response
Immunity
immunization
individual
induce
Infection
mRNA vaccination
mucosal
neutralizing antibody
Neutralizing antibody response
neutralizing antibody responses
offer
omicron
Reinfection
respiratory
respiratory tract
response
robust
SARS-CoV-2
severe disease
significantly lower
Support
T cell
T cell response
the SARS-CoV-2
vaccinated individuals
variant
variants of concern
virus
VOCs
with COVID-19
[DOI] 10.1126/sciimmunol.add4853 PMC 바로가기
[DOI] 10.1126/sciimmunol.add4853 PMC 바로가기